153 related articles for article (PubMed ID: 18521458)
1. Apolipoprotein B/apolipoprotein A-I ratio in relation to various definitions of metabolic syndrome among Saudi patients with type 2 diabetes mellitus.
Alfadda AA; Al-Daghri NM; Malabu UH
Saudi Med J; 2008 Jun; 29(6):821-5. PubMed ID: 18521458
[TBL] [Abstract][Full Text] [Related]
2. Comparison of apolipoprotein-B/apolipoprotein-AI in subjects with versus without the metabolic syndrome.
Sierra-Johnson J; Somers VK; Kuniyoshi FH; Garza CA; Isley WL; Gami AS; Lopez-Jimenez F
Am J Cardiol; 2006 Nov; 98(10):1369-73. PubMed ID: 17134631
[TBL] [Abstract][Full Text] [Related]
3. Adiponectin is independently associated with apolipoprotein B to A-1 ratio in Koreans.
Park JS; Cho MH; Nam JS; Yoo JS; Lee YB; Roh JM; Ahn CW; Jee SH; Cha BS; Lee EJ; Lim SK; Kim KR; Lee HC
Metabolism; 2010 May; 59(5):677-82. PubMed ID: 19914667
[TBL] [Abstract][Full Text] [Related]
4. Serum apolipoprotein B predicts dyslipidemia, metabolic syndrome and, in women, hypertension and diabetes, independent of markers of central obesity and inflammation.
Onat A; Can G; Hergenç G; Yazici M; Karabulut A; Albayrak S
Int J Obes (Lond); 2007 Jul; 31(7):1119-25. PubMed ID: 17299378
[TBL] [Abstract][Full Text] [Related]
5. High-sensitivity C-reactive protein and the hypertriglyceridemic waist in patients with type 2 diabetes and metabolic syndrome.
Rosolova H; Petrlova B; Simon J; Sifalda P; Sipova I
Med Sci Monit; 2008 Aug; 14(8):CR411-5. PubMed ID: 18667998
[TBL] [Abstract][Full Text] [Related]
6. Frequency of metabolic syndrome among hemodialysis patients according to NCEP-ATP III and IDF definitions.
Ucar E; Huzmeli C; Guven O; Savas N; Gullu M; Asilyoruk S; Kuvandik C; Temizkan A; Kuvandik G
Ren Fail; 2009; 31(3):221-8. PubMed ID: 19288328
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein A-I positively associated with diabetes in women independently of apolipoprotein E genotype and apolipoprotein B levels.
Onat A; Kömürcü-Bayrak E; Can G; Küçükdurmaz Z; Hergenç G; Erginel-Unaltuna N
Nutrition; 2010 Oct; 26(10):975-80. PubMed ID: 20116212
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein assays: methodological considerations and studies in non-insulin-dependent diabetes treated by diet, glibenclamide and insulin.
Billingham MS; Milles JJ; Green A; Bailey CJ; Hall RA
Scand J Clin Lab Invest; 1989 May; 49(3):239-47. PubMed ID: 2500699
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein B and insulin resistance are good markers of carotid atherosclerosis in patients with type 2 diabetes mellitus.
Matsumoto K; Fujita N; Nakamura K; Senoo T; Tominaga T; Ueki Y
Diabetes Res Clin Pract; 2008 Oct; 82(1):93-7. PubMed ID: 18684539
[TBL] [Abstract][Full Text] [Related]
10. Risk stratification of apolipoprotein B, apolipoprotein A1, and apolipoprotein B/AI ratio on the prevalence of the metabolic syndrome: the ATTICA study.
Pitsavos C; Panagiotakos DB; Skoumas J; Papadimitriou L; Stefanadis C
Angiology; 2008; 59(3):335-41. PubMed ID: 18388068
[TBL] [Abstract][Full Text] [Related]
11. Plasma markers of cholesterol homeostasis in metabolic syndrome subjects with or without type-2 diabetes.
Ooi EM; Ng TW; Chan DC; Watts GF
Diabetes Res Clin Pract; 2009 Sep; 85(3):310-6. PubMed ID: 19573945
[TBL] [Abstract][Full Text] [Related]
12. Adiponectin is an important determinant of apoA-I catabolism.
Vergès B; Petit JM; Duvillard L; Dautin G; Florentin E; Galland F; Gambert P
Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):1364-9. PubMed ID: 16574896
[TBL] [Abstract][Full Text] [Related]
13. The Apolipoprotein B/Apolipoprotein A 1 ratio in relation to metabolic syndrome and its components in a sample of the Tunisian population.
Belfki H; Ben Ali S; Bougatef S; Ben Ahmed D; Haddad N; Jmal A; Abdennebi M; Ben Romdhane H
Exp Mol Pathol; 2011 Oct; 91(2):622-5. PubMed ID: 21801720
[TBL] [Abstract][Full Text] [Related]
14. Diagnosing metabolic syndrome in type 2 diabetes: does it matter?
Song SH; Hardisty CA
QJM; 2008 Jun; 101(6):487-91. PubMed ID: 18353792
[TBL] [Abstract][Full Text] [Related]
15. Elevated lipoprotein (a) and apolipoprotein B to AI ratio in South Asian patients with ischaemic stroke.
Sharobeem KM; Patel JV; Ritch AE; Lip GY; Gill PS; Hughes EA
Int J Clin Pract; 2007 Nov; 61(11):1824-8. PubMed ID: 17935546
[TBL] [Abstract][Full Text] [Related]
16. The apolipoprotein B/AI ratio and the metabolic syndrome independently predict risk for myocardial infarction in middle-aged men.
Lind L; Vessby B; Sundström J
Arterioscler Thromb Vasc Biol; 2006 Feb; 26(2):406-10. PubMed ID: 16306426
[TBL] [Abstract][Full Text] [Related]
17. The relationship of serum lipoprotein lipase mass with fasting serum apolipoprotein B-48 and remnant-like particle triglycerides in type 2 diabetic patients.
Kobayashi J; Nakajima K; Nohara A; Kawashiri M; Yagi K; Inazu A; Koizumi J; Yamagishi M; Mabuchi H
Horm Metab Res; 2007 Aug; 39(8):612-6. PubMed ID: 17712727
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein B gene variants are involved in the determination of blood glucose and lipid levels in patients with non-insulin dependent diabetes mellitus.
Duman BS; Oztürk M; Yilmazer S; Cağatay P; Hatemi H
Cell Biochem Funct; 2006; 24(3):261-7. PubMed ID: 16634094
[TBL] [Abstract][Full Text] [Related]
19. Impaired subcutaneous adipocyte lipogenesis is associated with systemic insulin resistance and increased apolipoprotein B/AI ratio in men and women.
Hoffstedt J; Förster D; Löfgren P
J Intern Med; 2007 Jul; 262(1):131-9. PubMed ID: 17598821
[TBL] [Abstract][Full Text] [Related]
20. Increased apoB/A-I ratio independently associated with Type 2 diabetes mellitus: cross-sectional study in a Korean population.
Hwang YC; Ahn HY; Kim WJ; Park CY; Park SW
Diabet Med; 2012 Sep; 29(9):1165-70. PubMed ID: 22356423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
